Pharma Market Access Insights - from Mtech Access

Apr 09 2024 397
Pharma Market Access Insights - from Mtech Access Podcast artwork

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Mtech Access. Our first series focuses on the NHS response to the COVID-19 pandemic.

RSS feed Share
Copy RSS


Subscribe on Podcast Addict


How does funding flow in NHSE Regions?

Apr 09 2024 60 mins  
Which decisions are made at Region level in the NHS in England? How do finances and funding work at this level? And how can industry best support and engage with Region leaders?We sit down with guest speaker Richard Smale (Interim Director of System Co-ordination, NHS England [NHSE] – South West) for an all-encompassing discussion that explored finance, funding flows, system prio

NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)

Apr 09 2024 62 mins  
What do we know about plans and policy for 2024/25? As the expected central operating plan had not materialised (at time of recording), and with a general election and a potential Labour government on the horizon, how can NHS and industry drive forward improvements and innovation?Host Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) was joined by gues

De-mystifying health economic model classifications and structures

Mar 22 2024 60 mins  
What is health economic evaluation and which modelling approaches can be used to support market access activities?In this episode, our expert health economists explain the key strengths and limitations of the most common health economic modelling classifications and structures. Here, Hannah Gillies (Consultant – Health Economics) and Daniel MacDonald (Associate Consultant – Hea

Evidence strategy for Medical Technologies and Diagnostics

Mar 12 2024 53 mins  
Here, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies.Have you established the clinical and economic value of your medical device, diagnostic or digital technology? Do you have the evidence required to support your value proposition? Would a health technology assessment (HTA) route be appropriate for your product? What will p

How to set your Pharma or Medtech product up for success in the US market

Feb 26 2024 43 mins  
How can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice commercialisation strategy for healthcare products launching in the US market.Clare Foy (Director – Global Market Access, Mtech Access) speaks to Janice MacLennan (Pharma and Medtech brand strategi

What's happening with specialised commissioning in the NHS?

Feb 12 2024 60 mins  
What’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this uncertainty?Malcolm Qualie (former Medicines Lead for Specialised Services, NHS England) speaks to David Thorne (Principal Associate, Mtech Access) to explore specialised commissioning in

Integrated care in NHS Wales – what can England learn from its neighbour?

Jan 17 2024 56 mins  
What does it take to run a truly patient-centric integrated health system? What does the Welsh journey with integration tell us about the future for England?Paul Mears (CEO, Cwm Taf Morgannwg University Health Board) joins Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) to explore the integrated care model in Wales and the lessons England can take fr

Market access in Italy: Reforms at AIFA

Dec 18 2023 43 mins  
Clare Foy (Director – Global Market Access, Mtech Access) speaks to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and Outcomes Research [HEOR] and Ex-Payer) about the market access landscape in Italy, particularly regarding changes at the Agenzia Italiana del Farmaco (AIFA).We explore:- The nature of the Italian market and the reimbursement

Unmet need in NHS primary care – How can industry best support PCN leaders?

Nov 28 2023 60 mins  
Dr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) explore the unmet needs of Primary Care Networks (PCNs) and how industry can best support primary care leaders and GPs as we head into winter, 2024 and beyond.Former ‘GP of the year’ and strategic influencer over primary care policy, Dr Farzana Hus

Population health management: a community effort across health and life sciences

Nov 01 2023 64 mins  
How can our community support NHS leaders to deliver a data-led, people-centric health service?Dr Mark Davies (Global Chief Health Officer, IBM) joins Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) to explore the power of data, the role of community and how the health and life sciences ecosystem can support the NHS’s population health management goals.Po